Introduction
Over the past twenty years, nail disorders have gained increased attention. With the emergence of novel drugs, some conditions have become treatable, thus sparking further interest. Nail surgery, too, has evolved, which has led to the introduction of gentle surgical techniques for biopsy and excision.
Clinically, Bowen's disease usually presents as a fl at, verrucous lesion on the lateral or distal aspect of the nail (Figure 1 ). Involvement of the proximal nail fold results in an erythematous patch or fl at plaque with highly irregular borders whose true extent can frequently only be estimated by changes in the surface texture. Here, photodynamic diagnosis may be helpful. Extension below the nail or lesions originating from the nail bed and matrix are less common. Involvement of the matrix results in textural changes of the nail plate with loss of transparency and nail sheen. Subungual Bowen's disease may also manifest as an isolated red streak in the nail bed, often originating from the lunula. Onycholysis is common. In darkskinned individuals and in cases associated with HPV-56, ungual Bowen's disease is frequently pigmented (Figure 2 ) and may cause melanonychia.
The disease takes a chronic, progressive course. Frequently, the diagnosis is only made after many years, on average more than 4-5 years. A diagnostic biopsy is required. If left untreated, onycholysis progresses, and a crusted lesion may develop in the periungual area indicating the progression to invasive Bowen's carcinoma.
Histological examination reveals characteristics typical of carcinoma in situ: loss of normal stratifi cation throughout all epidermal layers, dyskeratosis, large clumped cells with hyperchromatic nuclei, atypical mitoses, and very often perinuclear vacuolization indicating association with HPV ( Figure 3 ) .
Treatment of choice is microscopically controlled surgery with three-dimensional assessment of the surgical margins. Alternatively, excision with surgical Bowen's disease is characterized by flat, verrucous periungual lesions, onycholysis, and longitudinal erythronychia.
Pigmented Bowen's disease is characteristic of dark-skinned individuals or cases associated with HPV56.
The histopathology of ungual Bowen's disease is pathognomonic.
Figure 1 Verrucous
Bowen's disease involving the lateral nail fold and nail wall .
Figure 2 Pigmented
Bowen's disease extending from the lateral nail bed to the hyponychium.
margins of 3-5 mm may be considered; here, too, complete histological assessment of the margins should be performed. If there is evidence of tumor invasion, it is usually recommended to remove the entire nail apparatus including clinically visible periungual components. Nonsurgical alternatives have been described and include photodynamic therapy, topical cytostatic treatment with 5-fl uorouracil, or topical immunotherapy with imiquimod. However, these therapies are less reliable, and, particularly in case of matrix and nail bed involvement, diffi cult to apply, given that the overlying nail must be cut and reliable clinical assessment of the true extent is impossible.
A wide range of clinical differential diagnoses must be considered, including viral warts, chronic eczema, mycosis, onychopapilloma, as well as subungual exostosis and other malignancies.
Squamous cell carcinoma of the nail apparatus
The majority of SCCs of the nail apparatus originate from advanced Bowen's disease lesions. It is therefore not surprising that lesions may have been present for years, sometimes more than a decade. Depending on the location within the nail apparatus, clinical manifestations may include 1) a hard keratotic tumor on the proximal or lateral nail fold that tends to ulcerate and subsequently form a scab; 2) an onycholytic area with yellow discoloration of the overlying nail (Figure 4 a, b) and frequent oozing, which is considered a late symptom; or 3) a verrucous lesion.
Treatment of choice is complete excision with sufficient surgical margins.
PDT, 5-fluorouracil, and imiquimod are alternatives but less reliable.
Differential diagnosis: viral warts, eczema, onychomycosis, and or tumors.
A hard keratotic nodule that tends to ulcerate or onycholysis with oozing are characteristic features of ungual squamous cell carcinoma. Given that no nail-specifi c TNM classifi cation has to date been devised, tumors are classifi ed in analogy to SCCs of the skin.
The disease takes a chronic, progressive course. Pain may occur in the context of osseous invasion, however, this is very rare. In exceptional cases, metastasis has been observed.
Histologically, two types can be distinguished: Bowen's carcinoma and common SCC without cytopathic effects. The latter corresponds to SCC of the skin and is HPV-negative ( Figure 5 ) [ 2 ] . Generally, Bowen's carcinoma has the same characteristics as Bowen's disease. It does, however, have invasive components. The common SCC type is quite rare in the nail region and is characterized by marked cellular atypia, pathological mitoses, premature keratinization, and single cell necroses. Koilocytosis, as observed in HPV-associated types, is missing.
Treatment of choice is complete excision with three-dimensional assessment of excision margins (Figure 6 a, b) ; there are no specifi c recommendations for Bowen's disease and SCC of the nail apparatus in the guidelines issued by the Association of the Scientifi c Medical Societies in Germany ( Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF ) [ 3 ] . If Mohs surgery is not available, 5-mm surgical margins are recommended for Bowen's disease and early invasive SCC. Fluorescence studies with 5-aminolevulinic acid can facilitate the differentiation from healthy tissue. If there is osseous invasion, limited amputation should be considered.
The disease takes a chronic course.
Histologically, two types can be distinguished.
Treatment of choice is wide excision, preferably with three-dimensional histological assessment or 5-mm surgical margins. Figure 5 Early invasive subungual squamous cell carcinoma with a dense inflammatory infiltrate (hematoxylin-eosin stain, original magnification x100).
Figure 6
Subungual squamous cell carcinoma revealing an oozing tumor after removal of the nail plate; prior to biopsy (a), following diagnostic confirmation, the entire nail apparatus is excised (b).
Melanoma of the nail
Without a doubt, melanoma is the most serious diagnosis in onychology. Twothirds to three-quarters of ungual melanoma lesions are pigmented. Their diagnosis therefore presents no challenge -melanoma merely has to be considered as possible cause. Unfortunately, this is still very often not the case, as has been shown by large case series with a mean tumor thickness of four or more millimeters. Some patients had had to point out to their doctor for many years that "something was not right", before they were fi nally referred to a specialist. By contrast, the diagnosis of amelanotic subungual melanoma is very challenging [ 4 ] . A longitudinal brown streak in the nail, referred to as longitudinal melanonychia, always originates from the matrix. It may be caused by activation of matrix melanocytes (Figure 7 ) -functional melanonychia; proliferation of active melanocytes ( Figure 8 ) -matrix lentigo; a nevus (Figure 9 ), or melanoma ( Figure 10 ).
The diagnosis of nail melanoma is frequently delayed or not made at all.
Figure 7
Functional melanonychia in a 51-year-old woman. The diagnosis is critical and must always be confirmed histopathologically. Figure 8 Longitudinal melanonychia due to a lentigo of the matrix in a young woman with skin type 5.
Clinically, said entities cannot be reliably differentiated based on the pigmented band alone. It is not the intensity of the color that is important but the structure of the brown streak. In benign melanonychia, it consists of fi ne, regular, parallel, symmetric longitudinal lines on a gray (functional melanonychia) or brown (lentigo) base. In nevi, there are frequently brown dots, which correspond to the transungual elimination of nevus cell nests. In melanoma, both the band and pigmentation are irregular and asymmetric. The lines are not parallel, and the band is sometimes wider at the proximal than at the distal end, indicating tumor growth ( Figure 11 ). The base is supposed to have a slightly red color in melanoma, as
Clinical suspicion should be raised in case of an irregular band and nail dystrophy. In addition, the older the patient at the onset of melanonychia, the more suspicious the lesion is. Figure 9 Longitudinal brown streak in the nail due to a melanocytic nevus of the matrix. Figure 11 Subungual melanoma of the big toe in a 62-year-old man. The color is inhomogeneous, and the band is wider at the proximal than at the distal end, indicating tumor growth. Figure 10 Subungual melanoma in situ of the big toe in a 58-year-old woman.
proportionally more pheomelanin is produced. Periungual pigmentation is known as Hutchinson's sign ( Figure 12 ) and is generally considered diagnostic for melanoma (with the exception of congenital nevi). Nail dystrophy, no matter how small, constitutes evidence of advanced melanoma that has caused thinning of the epithelium.
In the assessment of longitudinal melanonychia, the age at onset is very important ( Table 1 ). The exact location is also relevant: although all nails may be affected, ungual melanomas most commonly occur on the thumb, big toe, middle and index fi nger.
Other factors are summarized in the ABCDEF rule (Table 2 ) . Apart from melanin in the nail, brown or black discoloration can be caused by many other substances. Most common is subungual hematoma, which may occur as a result of a single, severe trauma or recurrent microtraumata due to friction in shoes or activities such as hiking and certain types of sport. Both the color and the extent of pigmentation facilitate the differentiation from longitudinal melanonychia. In the latter, the pigment always extends to the distal nail edge as the melanin is embedded in the nail. Some fungi produce soluble melanin. If streaky, it is seen as pigmentation that starts distally and extends proximally, often forming a narrow wedge that is wider at the distal end. Bacterial pigmentation is usually peripheral or limited to onycholytic nail areas. In case of Klebsiella and Proteus species, they are rather dirty-gray; in case of Pseudomonas aeruginosa , greenish-black. They rarely form bands of regular width and can be scraped off the nail surface. Silver nitrate applied to the nail permeates the upper third; it has a deep black color and Longitudinal melanonychia is due to increased melanin synthesis in the matrix.
Location of nail melanoma. grows out with the nail. Potassium permanganate causes a diffuse brown discoloration of the nail and the surrounding skin. Using ascorbic acid 10 %, it can be reduced to colorless manganese oxide. In heavy smokers, too, only one side of the fi ngertip is discolored along with the nail.
Human melanin in the nail can be detected by staining a piece of the distal edge of the nail with the Fontana-Masson stain. Histology reveals fi ne melanin granules inside nail cells. These fi ndings clearly differ from those seen following silver nitrate application. Henna laced with p-phenylenediamine can also give rise to very dark pigmentation, which grows out by forming a convex border parallel to the free edge of the nail fold ( Figure 13 ). Fungal melanin has a diffuse, slightly yellow color and, in our experience, cannot be stained with the Fontana-Masson silver stain. In subungual hematoma, blood is not degraded to hemosiderin; accordingly, no hemosiderin is formed and staining with Prussian blue is negative. Blood can be readily identifi ed using the benzidine reaction or patent blue.
The most important measure in the diagnosis of ungual melanoma is to merely consider melanoma when faced with adult-onset streaky nail pigmentation. Only then are further diagnostic considerations made and tests performed.
The diagnosis of amelanotic nail melanoma poses a genuine challenge. Nearly all lesions originate from the nail bed, which physiologically contains far fewer melanocytes than the matrix. When occurring in the lateral nail bed, it frequently presents as wart, pyogenic granuloma, exostosis, or ingrown nail. Entirely subungual amelanotic melanomas cause onycholysis and, rarely, lichen planus-like lesions [ 5 ] . Onycholysis associated with oozing is indicative of an eroded or ulcerating tumor.
The internal structure of melanonychia is prognostically important.
Differential diagnosis of the pigment.
Pigment detection in the nail: human melanin is granular, intracellular, and can be stained with silver; fungal melanin is diffuse and cannot be visualized using the Fontana stain; blood is Prussian blue-negative. The most important measure in the diagnosis of ungual melanoma is to merely consider melanoma when faced with adult-onset streaky nail pigmentation.
The diagnosis of amelanotic melanoma is challenging. Figure 13 Dark brown discoloration of the toe nails due to henna laced with p-phenylenediamine. The exogenous pigmentation grows out by forming a convex border parallel to the cuticle.
Histopathologically, nail melanomas essentially exhibit the same features as cutaneous melanomas. While invasive tumors pose no histological challenge, the diagnosis may be diffi cult or even impossible in very early stages or at the periphery of the lesion. Though proposed by some authors, counting the number of melanocytes per millimeter of basal layer is not feasible for very early lesions. Given that the histology of a biopsy taken from the area of the Hutchinson's sign is frequently rather bland, it is generally not recommended to take a biopsy in this area. The matrix of in situ melanomas is often densely colonized by melanocytes, which may extend along the underside of the proximal nail fold towards the cuticle. Even in very extensive melanoma lesions, there are frequently only relatively few melanocytes in the nail bed, whereas their number increases again in the hyponychium. Immunohistochemically, melanocytes have been reported to show particularly plump dendrites [ 6 ] . When assessing the biopsy of a lesion suspicious for melanoma, the patient's age, too, should always be taken into account. In this context, one particular problem regarding the histological diagnosis of melanonychia in children and adults must be addressed. In children, the cytology of matrix biopsies is often very alarming, as there are many atypical cells and hyperchromatic nuclei. In adults, it is the opposite: the histological changes are frequently quite unremarkable, in particular if the biopsy was taken from the area of the Hutchinson's sign, which should generally not be done. Melanocytic lesions with bland morphology may biologically already be (pre)malignant. It is imperative that the dermatopathologist point this out to the sender of a matrix biopsy taken from an adult with melanonychia.
While treatment of ungual melanoma has signifi cantly changed in recent years, it is scarcely mentioned in the current AMWF guidelines. There is no offi cial classifi cation according to Clark and Breslow, given the diffi culties in measuring tumor thickness (Breslow) due to the missing granular layer and determining the Clark level due to lack of a clearly defi ned border between papillary and reticular dermis. Neither do the guidelines provide any recommendation with respect to sentinel lymph node biopsy in nail melanoma; it should therefore be done in analogy to cutaneous melanoma. If in the past the amputation of a fi nger or a toe, or even of the entire ray, was virtually a refl ex, it has become evident that the function-conserving, generous excision of the nail apparatus with preservation of the distal phalanx, which we have propagated for in situ and early invasive melanoma for 40 years [ 7 ] , is at least on par with amputation with respect to disease-free survival [ 8 ] . Amputation is only recommended for advanced melanoma [ 9 ] . In this context, however, the -somewhat polemic -question arises whether, at that point, it is not too late for amputation as well.
Function-conserving surgery of early nail melanoma is performed under nerve block. The nail apparatus is dissected from the bone of the distal phalanx with surgical margins of 6 mm around its anatomical boundaries, while sparing the bony insertion of the extensor tendon. It is important to also ensure the complete removal of the lateral matrix horns. If a Hutchinson's sign is present, surgical margins of 10 mm are recommended as molecular biology methods have demonstrated so-called fi eld cells in the epidermis around lentiginous melanoma lesions at a distance of up to 9 mm from the visible borders [ 10 ] . Some centers recommend Mohs microscopically controlled surgery.
Follow-up after surgery of ungual melanoma is analogous to that of cutaneous melanoma. Depending on the tumor thickness, follow-up exams are scheduled at three-to six-month intervals; after three to fi ve years, at six-to twelve-month intervals.
While the histopathology of invasive ungual melanoma is characteristic, that of early melanoma in situ is frequently very challenging.
Particular histological problems in pediatric and adult melanonychia.
Shift in treatment from amputation to generous local excision.
Functional surgery: excision of the nail apparatus with surgical margins of 6 mm; in case of Hutchinson's sign, 10 mm.
Follow-up as for cutaneous melanoma.
Superficial acral fibromyxoma
First described in 2001, this tumor is apparently quite common. Although the age of onset can vary from 4 to 86 years, middle-aged adults are predominantly affected by this slowly growing tumor developing on fi ngers or toes; about 50 % of lesions are located under or around the nail ( Figure 14 ) . Today also referred to as digital fi bromyxoma, this nontender tumor usually grows to a size between 5 mm and 5 cm [ 11 ] . The sheer extent of the tumor can lead to nail deformation or even destruction. Bone erosion may occur. Histology reveals a well-demarcated myxofi bromatous tumor. Treatment of choice is complete excision, which may, however, be technically challenging in case of subungual lesions. Accordingly, the recurrence rate is approximately 25 %. To date, there have been no reports of malignant transformation.
The differential diagnosis includes all fi bromatous tumors and pseudotumors.
"Onycho"-tumors
Since the fi rst description of an "onycho-tumor" in 1983 [ 12 ] , a number of other benign and malignant neoplasms have been added to the list. In analogy to hair follicle tumors, they are classifi ed -based on their origin -as onychocytic and onycholemmal, onychomatricoma and onychopapilloma. Onychocytic tumors originate from matrix cells, while onycholemmal tumors originate from the nail bed. Below, an attempt is made to describe this diverse group with its somewhat confusing nomenclature according to its anatomical origin from proximal to distal, that is, from the matrix to the nail bed.
Onychomatricoma
First described 25 years ago [ 13 ] , onychomatricoma is characterized by circumscribed thickening of the nail with yellow discoloration (Figure 15 a) . Within the nail, there are longitudinal channels that contain fi nger-like protrusions consisting of connective tissue including capillaries, which are responsible for its striated macroscopic appearance and the splinter hemorrhages. These are readily visible on dermatoscopy. The thick free edge of the nail has small holes (Figure 15 b) that sometimes still contain tumor projections and patent capillaries; if this is the case, the nail may bleed during nail cutting, which does not occur with any other nail tumor. To date, approximately 250 cases of onychomatricoma have been reported. The clinical variability is solely based on differences in the location within the nail Digital fibromyxoma is a slowly growing tumor that can lead to nail deformation.
Figure 14
Histopathology of superficial acral fibromyxoma that has grown both under the matrix as well as into the proximal nail fold (hematoxylin-eosin stain, original magnification x100).
Histopathology is characteristic.
Treatment of choice is complete excision.
Based on their origin, nail-specific tumors have been designated as onychocytic, onycholemmal, onychomatricoma, or onychopapilloma.
Onychomatricoma is characterized by thickening, yellow discoloration, increased transverse curvature, longitudinal striations, and splinter hemorrhages.
"Bleeding nail" during nail cutting is a unique feature of onychomatricoma.
apparatus as well as the pigmentation occasionally observed. Careful removal of the nail exposes the actual tumor with its long, slender protrusions that resemble intestinal villi. Given that they are all covered by functionally active matrix epithelium, which results in a massive increase in the nail-generating surface, considerably more nail substance is produced, thus giving rise to said thickening and yellow discoloration.
Onychomatricoma is characterized by a slightly different keratin structure, which may possibly explain the greater prevalence of fungal infections and colonization with Pseudomonas aeruginosa . Histologically, it is a fi broblastic tumor with a dense, highly cellular stroma as well as delicate collagen fi bers. Its fi liform projections are covered by matrix epithelium, which frequently extends deep into the tumor where it forms characteristic fi ssures (Figure 16 a) . The longitudinal section of the nail reveals long parallel channels lined with superfi cial layers of the matrix epithelium; these channels contain poorly structured edematous connective tissue. The transverse section reveals round cavities with the same wall lining and internal structure (Figure 16 b) .
As regards treatment, complete excision used to be the recommended, which, however, virtually always resulted in defects. Tangential removal seems to be Pigmented onychomatricoma may mimic melanoma. Figure 15 Onychomatricoma. The dorsal view shows a segmentally distinctly thickened nail with yellow striations (a). The end-on view shows the enormously thickened nail with numerous small holes (b).
Histologically, it is a biphasic, benign tumor. Figure 16 Histopathology of onychomatricoma. The stroma of the tumor is highly cellular and contains abundant fibers. It is covered by basal layers of the matrix epithelium. The papillomatous surface can be seen (a). The transverse section of the nail shows multiple channels in the nail that are lined by superficial layers of the matrix epithelium (b) (hematoxylin-eosin stain, original magnification a x50, b x 100).
associated with complete remission. While relapse is possible, recurrent lesions are usually much less pronounced.
Onychocytic matricoma
First described as linear keratotic melanonychia and subsequently as subungual seborrheic keratosis, onychocytic matricoma constitutes a proliferation of the basal cell layer of the matrix, very much resembling seborrheic keratosis. However, unlike seborrheic keratosis of the "outer" skin, it does not "sit on the matrix" but slightly protrudes into the connective tissue of the matrix. Clinically, onychocytic matricoma presents as a light-brown longitudinal band in the nail (Figure 17 ) , with keratotic thickening at the free edge. The level of pigmentation can vary from mild to very pronounced [ 14 ] . On dermatoscopy, the nail does not appear thinner in this area. Histology reveals an acanthoma predominantly made up of basophilic cuboid cells. In analogy to the pseudocysts observed in seborrheic keratosis, the lesion contains eosinophilic "nail pearls" -horny inclusions -that are surrounded by a prekeratogenous and a keratogenous zone.
The differential diagnosis encompasses longitudinal melanonychia including subungual melanoma, onychopapilloma, Bowen's disease, onychocytic carcinoma, subungual acantholytic dyskeratotic acanthoma, and early onychomatricoma. Treatment of choice is tangential excision sparing the matrical dermis.
Onychocytic carcinoma
Onychocytic carcinoma, too, has only recently been described [ 15 ] . Clinically, it presents as thickening of the nail with an irregular surface. The transverse curvature is more pronounced. Due to the thickening, the nail tends to appear yellow. The area around the nail is not involved. Clinical differential diagnoses primarily include onychocytic matricoma, onychomatricoma, onychopapilloma, and Bowen's disease.
Histological examination shows a well-demarcated epithelial tumor. Unlike Bowen's disease, it exhibits small fi nger-like epithelial protrusions with a regular prekeratogenous zone, from which small cavities originate. These characteristics contribute to the onychomatricoma-like appearance of onychocytic carcinoma. The deeper part of this carcinoma in situ predominantly consists of basaloid cells, usually with only mild cellular atypia, dyskeratosis, and frequently also clear cells. The mitotic rate is relatively low (Figure 18 ).
Onychocytic matricoma originates from the matrix epithelium. Clinically, it usually presents as a moderately pigmented subungual band.
Clinical differential diagnosis: other "onycho-tumors".
Figure 17
Onychocytic matricoma presenting as an ill-defined light-brown band in the nail.
Treatment of choice is complete excision with suffi cient surgical margins. Although there is no long-term experience yet, it is apparently a low-grade malignancy.
Onychopapilloma
Though relatively common, onychopapilloma is a "young" tumor of the distal matrix [ 16 ] . Clinically, it generally presents as a longitudinal, 4-8 mm wide band of gray-white, red, or light-brown color that extends from the distal lunula to the distal edge of the nail. Splinter hemorrhages and V-shaped distal onycholysis, frequently associated with nail fi ssures, are common ( Figure 19 ) . Looking under the edge of the nail reveals subungual keratosis. Given that onychopapilloma originates from the distal matrix, which would normally also be involved in nail formation, the nail is slightly thinner above the keratin of the onychopapilloma.
The histological picture varies from the matrix to the hyponychium; it must be pointed out that, unlike onychocytic matricoma, the nail apparatus is virtually affected along its entire length. The matrix component of the tumor shows an endo-exophytic acanthoma, which may contain many clear cells that resemble sebaceous gland cells. The lesion is characterized by deep clefts as well as protrusion into the overlying nail (which explains the nail thinning). Furthermore, the tumor produces keratin, which -unlike healthy nail -is intensely eosinophilic (Figure 20 ). In the nail bed, the tumor fl attens; here, the dermis frequently shows many small inclusions, some of them solid and some corresponding to small onycholemmal cysts. The epithelium itself reveals some multinucleated keratinocytes. Figure 18 Onychocytic carcinoma. The histopathology is similar to Bowen's disease, however, there is a well-developed prekeratogenous and eosinophilic keratogenous zone as well as a papillomatous surface (hematoxylin-eosin stain, original magnification x100).
Onychopapilloma is common. Clinically, it presents as a longitudinal, 4-8 mm wide band of gray-yellow, red, or lightbrown color. Figure 19 Onychopapilloma of the thumb with a slightly red band extending from the distal matrix to the distal third of the nail bed; distally, there is localized onycholysis and a nail fissure.
In the distal nail bed, the epithelium is sunk in and only slightly acanthotic. PAS staining frequently shows invasive hyphae. Therapeutically, complete longitudinal excision with primary wound closure may be considered. We prefer suffi ciently deep tangential excision, which must extend from the hyponychium to the middle of the matrix. Usually, the nail grows back normally. The recurrence rate is approximately 5 %.
Subungual acantholytic dyskeratotic acanthoma (SADA)
To date, only very few cases of SADA have been reported [ 17 ] . However, given that we have observed fi ve cases of our own, it is quite conceivable that some previous cases were diagnosed incorrectly and misinterpreted as onychopapilloma. Clinically, it is also characterized by a yellow-gray, red, or light-brown longitudinal band that presents as circumscribed subungual keratosis under the free edge of the nail (Figure 21 ). There are no subjective symptoms. Clinically suspected to be onychopapilloma, all of our cases were surgically removed by tangential/longitudinal excision.
Histology reveals long, slender epithelial ridges -almost parallel to the nail bed -with longitudinal clefts due to acantholysis (Figure 22 ). Moreover, there is dyskeratosis and, occasionally, large atypical cells and mitoses. In the area of the matrix, the exophytic component is less pronounced. Distally, the keratosis is more There is a red longitudinal streak proximal to the onycholysis that originates in the distal lunula. lamellar. The differential diagnosis includes the very rare subungual variant of warty dyskeratoma, which is located more distally.
It is still open to debate whether SADA constitutes a separate entity or is perhaps merely an acantholytic, dyskeratotic variant of onychopapilloma.
Onycholemmal horn
First described in 1983 [ 12 ] , this nontender, nail-specifi c tumor is characterized by very slow growth. Clinically, it presents as a hard nodule at the edge of the nail bed. Although the tumor originates from the nail bed epithelium, it may secondarily extend to the adjacent matrix and thus affect nail growth. Its designation was chosen due to its very pronounced clinical and histological similarity to trichilemmal horn. The clinical differential diagnosis includes Bowen's disease, squamous cell carcinoma, keratoacanthoma, proliferating onycholemmal tumor, warts, exostoses, and many more.
Histology reveals an epithelial tumor with characteristics of the nail bed. Basally, it is made up of small cuboid cells that rapidly develop into large, pale cells marked by abrupt keratinization. Circumscribed areas may show keratohyalin-containing cells. Keratinization of single cells is relatively common. Crater formation similar to keratoacanthoma is possible; alternatively, the tumor grows in an endophytic-papillomatous manner (Figure 23 ). The histological differential diagnosis primarily includes subungual keratoacanthoma, proliferating onycholemmal tumor, and dyskeratotic subungual tumors associated with incontinentia pigmenti. Though common, onycholemmal cysts are clinically rarely diagnosed, as they do not cause any symptoms. Occasionally, there is onycholysis due to subungual hyperkeratosis. Histology usually shows multiple small cysts, some with solid, others with central onycholemmal keratinization (Figure 24 ). Given their potential for calcification [ 18 ] , they may become radiographically visible (small spots). Onycholemmal cysts are frequently incidental fi ndings in excisions performed for other reasons, for example, subungual melanoma.
Proliferating onycholemmal tumor
This term was chosen in analogy to proliferating trichilemmal tumor. Clinically, it presents as an indistinctive, usually mildly exophytic tumor with a low tendency for keratinization. Predilection site is the lateral nail fold. The lesion causes no pain and grows very slowly.
Histology reveals a solid tumor made up of large tumor cell aggregates. The basal layer consists of small and cuboid cells that rapidly increase in size and abruptly keratinize without forming a horn. As dyskeratosis is common, there is a strong resemblance with the subungual tumors associated with incontinentia pigmenti (Figure 25 ) [ 19 ] .
Onycholemmal cysts are only diagnosed histologically.
Figure 24
Subungual onycholemmal cysts in a female patient with subungual melanoma. This is likely a chance association (hematoxylin-eosin stain, original magnification x200). 
Proliferating onycholemmal cyst
To date, proliferating onycholemmal cyst has not been clearly defi ned. It is a conglomerate of large onycholemmal cysts with distinct wall proliferation and narrow epithelial strands in between that are made up of two rows of cuboid cells ( Figure  26 ). Clinically, this subungual tumor is rather annoying than painful [ 17 ] . A malignant variant has also been described [ 20 ] .
Onycholemmal carcinoma
Onycholemmal carcinoma is a rare variant of subungual squamous cell carcinoma [ 21 ] . While it cannot be diagnosed as such solely on clinical grounds, its clinical presentation as an exophytic, nontender, frequently oozing, and usually longstanding tumor is suspicious for a carcinomatous lesion (Figure 27 ) .
Histologically, areas of ordinary squamous cell carcinoma alternate with areas of pale cells and abrupt keratinization similar to trichilemmal carcinoma.
To date, metastasis has not been described. Microscopically controlled surgery is the treatment of choice.
Conclusion
The nail apparatus shows a remarkable variety of tumors. This can be explained by the fact that it is part of the functional unit of the digital tip. As a consequence, Figure 26 Proliferating onycholemmal cysts with highly irregular epithelial formations (hematoxylineosin stain, original magnification x50).
Figure 27
Onycholemmal carcinoma of the big toe after inadequate surgical treatment of an ingrown nail more than 40 years earlier and recurrent "spontaneous" nail loss (hematoxylin-eosin stain, original magnification x50).
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